InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank14
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-7.77M
↓ 14% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-6.79M
Historical baseline
PeriodValueYoY Change
2025$-7.77M-11.2%
2024$-6.99M+4.1%
2023$-7.28M+53.3%
2022$-15.58M-59.2%
2021$-9.79M-32.8%
2020$-7.37M-10.4%
2019$-6.68M-81.6%
2018$-3.68M-55.5%
2017$-2.37M-512.7%
2016$-386071.82-